Pulmonary Tuberculosis in Children: A Forgotten Disease?

Area of Science:

• Pediatric Infectious Diseases
• Clinical Microbiology
• Public Health

Background:

• Childhood tuberculosis (TB) is frequently undiagnosed and undertreated, posing significant risks of severe disease and mortality in young children.
• Non-specific symptoms in pediatric TB often mimic other infections, complicating early and accurate diagnosis.
• Antituberculosis drug regimens require age-specific dosing and combinations for effective pediatric treatment.

Purpose of the Study:

• To review current diagnostic and therapeutic strategies for childhood tuberculosis.
• To highlight advancements in diagnostic techniques for pediatric TB.
• To emphasize the importance of tailored treatment approaches in children.

Main Methods:

• Review of diagnostic modalities including Interferon gamma release assay (IGRA) and Xpert Mtb/RIF Ultra.
• Analysis of treatment guidelines for susceptible and resistant pediatric TB.
• Consideration of age-specific drug dosages and combination therapies.

Main Results:

• Interferon gamma release assay (IGRA) shows preference over Mantoux testing, despite limitations in children under two years.
• Xpert Mtb/RIF Ultra is recommended for initial diagnosis using gastric aspirate or stool samples in symptomatic children.
• Brief therapeutic regimens are preferred for both latent and active pediatric TB, reducing adverse effects.

Conclusions:

• Advancements in diagnostics are enabling more rapid identification of pediatric tuberculosis infections.
• Adapted treatment strategies, including brief therapy and age-appropriate dosing, are crucial for managing childhood TB.
• Improved diagnostic and therapeutic approaches are essential to combat the burden of childhood tuberculosis.